Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Wickström, Anne; Nyström, Josefina; Svenningsson, Anders

doi:10.1177/1352458512461391

Research article2013Peer reviewed

Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment

Wickström, Anne; Nyström, Josefina; Svenningsson, Anders

Abstract

Conclusions: Our data support the notion that early inflammatory control in MS is essential to preserve a healthy state in MS that counteracts the negative consequences of the disease both at a personal and at a societal level.

Keywords

Multiple sclerosis; work ability; biological drugs; natalizumab

Published in

Multiple Sclerosis
2013, volume: 19, number: 5, pages: 622-630
Publisher: SAGE PUBLICATIONS LTD

SLU Authors

Nyström, Josefina
- Department of Forest Biomaterials and Technology, Swedish University of Agricultural Sciences

Global goals (SDG)

SDG8 Decent work and economic growth

UKÄ Subject classification

Neurosciences
Neurology

Publication identifier

DOI: https://doi.org/10.1177/1352458512461391

Permanent link to this page (URI)

https://res.slu.se/id/publ/53989